SCHEMBL4904034

SCHEMBL4904034

CCN(c1ccc(-c2ccc(F)cc2)cc1)S(=O)(=O)c1ccc(C)c(C(=O)OC)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
TSHR P16473 3/20 0.49
MAPK1 P28482 2/20 0.49
HSD17B10 Q99714 2/20 0.49
KMT2A Q03164 1/20 0.49
ALDH1A1 P00352 3/20 0.46
MAPT P10636 1/20 0.46
NPSR1 Q6W5P4 2/20 0.46
POLB P06746 2/20 0.46
ATM Q13315 1/20 0.45
ESR1 P03372 2/20 0.45
TP53 P04637 1/20 0.42
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
HPGD P15428 1/20 0.42
ALOX15 P16050 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4905926 0.92 LMNA (0.49) LMNATSHRMAPK1HSD17B10KMT2A
SCHEMBL4903997 0.92 MAPT (0.49) LMNATSHRMAPK1HSD17B10KMT2A
SCHEMBL4908535 0.92 LMNA (0.54) LMNATSHRMAPK1HSD17B10KMT2A
SCHEMBL4906761 0.91 ALDH1A1 (0.48) LMNATSHRHSD17B10ALDH1A1MAPT
SCHEMBL4905482 0.91 NPSR1 (0.51) LMNATSHRHSD17B10ALDH1A1MAPT
SCHEMBL4902995 0.90 HCRTR2 (0.47) LMNATSHRHSD17B10ALDH1A1MAPT
SCHEMBL4898279 0.89 MAPT (0.51) LMNATSHRALDH1A1MAPTPOLB
SCHEMBL4899320 0.89 ALDH1A1 (0.52) LMNATSHRHSD17B10KMT2AALDH1A1
SCHEMBL4905088 0.89 LMNA (0.51) LMNATSHRALDH1A1MAPTNPSR1
SCHEMBL4905415 0.89 ALDH1A1 (0.50) LMNATSHRMAPK1HSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885TSHR 400/4885MAPK1 3366/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885TSHR 400/4885MAPK1 3366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.